J4E Stock Overview
Through its subsidiaries, engages in cultivation and production of cannabis products for medical purposes in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MTL Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.16 |
| 52 Week High | CA$0.46 |
| 52 Week Low | CA$0.075 |
| Beta | 0 |
| 11 Month Change | -1.80% |
| 3 Month Change | 1.23% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| J4E | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -6.3% | -5.6% | -0.1% |
| 1Y | n/a | -18.5% | 2.3% |
Return vs Industry: Insufficient data to determine how J4E performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how J4E performed against the German Market.
Price Volatility
| J4E volatility | |
|---|---|
| J4E Average Weekly Movement | 31.6% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: J4E's share price has been volatile over the past 3 months.
Volatility Over Time: J4E's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Mike Perron | www.mtlcannabis.ca |
MTL Cannabis Corp., through its subsidiaries, engages in cultivation and production of cannabis products for medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. The company produces various cannabis products, including lines of dried flower, pre-rolls, and hash marketed under the MTL Cannabis, Low Key by MTL, and R’belle brands names.
MTL Cannabis Corp. Fundamentals Summary
| J4E fundamental statistics | |
|---|---|
| Market cap | €22.60m |
| Earnings (TTM) | -€3.56m |
| Revenue (TTM) | €14.61m |
0.0x
P/S Ratio0.0x
P/E RatioIs J4E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| J4E income statement (TTM) | |
|---|---|
| Revenue | CA$21.56m |
| Cost of Revenue | CA$6.28m |
| Gross Profit | CA$15.27m |
| Other Expenses | CA$20.52m |
| Earnings | -CA$5.25m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did J4E perform over the long term?
See historical performance and comparison